Samuel is the first Canadian and the ninth patient worldwide to participate in the second phase of a study using gene therapy to treat Glycogen storage disease type I, otherwise known as GSD.

The RI-MUHC is seeking a dynamic and strategic leader to serve as its next Executive Director and Chief Scientific Officer (ED/CSO)

Cell-based cancer vaccines are revolutionizing the treatment of previously incurable cancers

In two recent studies, RI-MUHC researchers provide useful information for evaluating public health strategies

A postdoctoral fellow from the RI-MUHC is recognized for international work on TB diagnostics

A $109M fund aims to mitigate impact of the pandemic on care delivery in Canada and beyond, as well as contribute to better understanding of the disease

Dermatology resident Abdulhadi Jfri shares his thoughts on undertaking a simultaneous Master’s degree

Sixteen new matches made, eight project funded: life sciences researchers meet data scientists

RI-MUHC research team, Emily McDonald and Todd C. Lee, ties for Marika Zelenka Roy Innovation Prize

“With science under attack, scientists have little choice but to step into the limelight and fight for what matters most” – Dr. Madhukar Pai